Preneoplastic oral lesions:: The clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression

被引:0
作者
Högmo, A [1 ]
Lindskog, S
Lindholm, J
Kuylenstierna, R
Auer, G
Munck-Wikland, E
机构
[1] Karolinska Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Oral Pathol, Stockholm, Sweden
[3] Karolinska Hosp, Dept Tumour Pathol, S-10401 Stockholm, Sweden
[4] Danderyd Hosp, Dept Tumour Pathol, Stockholm, Sweden
关键词
DNA; p53; p21/WAF1; leukoplakia; mouth neoplasm;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Various mucosal lesions are frequently encountered in the oral cavity. Neither macroscopic nor microscopic evaluation of these lesions gives any reliable information concerning the risk of cancer development. Material and methods: From 21 patients, 29 mucosal lesions were found to precede development of invasive squamous cell carcinoma or carcinoma in situ at the same location. The lesions were matched to 29 control lesions, with the same grade of dysplasia and from exactly the same locations but without subsequent cancer during a mean follow up of 112 months (46-194). The specimens were evaluated using Image Cytometry DNA analysis and immunohistochemical analysis of p53 and p21/WAF1 expression. Results: Lesions prior to carcinomatous development displayed a higher degree of DNA aberration as compared with the control lesions, p53 and p21/WAF1 evaluation did not reveal any differences between cases and controls. Conclusion: Image Cytometry DNA analysis is an useful adjunct to histopathological evaluation of oral mucosal lesions fbr prediction of risk of malignant transformation.
引用
收藏
页码:3645 / 3650
页数:6
相关论文
共 50 条
[31]   Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues [J].
Ito, Y ;
Kobayashi, T ;
Takeda, T ;
Komoike, Y ;
Wakasugi, E ;
Tamaki, Y ;
Tsujimoto, M ;
Matsuura, N ;
Monden, M .
BRITISH JOURNAL OF CANCER, 1996, 74 (08) :1269-1274
[32]   Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients [J].
Fu, CG ;
Tominaga, O ;
Nagawa, H ;
Nita, ME ;
Masaki, T ;
Ishimaru, G ;
Higuchi, Y ;
Tsuruo, T ;
Muto, T .
DISEASES OF THE COLON & RECTUM, 1998, 41 (01) :68-74
[33]   The role of p53, p21(WAF1)/(C1P1), and bcl-2 in radioresistant colorectal carcinoma [J].
Palazzo, JP ;
Kafka, NJ ;
Grasso, L ;
Chakrani, F ;
Hanau, C ;
Cuesta, KH ;
Mercer, WE .
HUMAN PATHOLOGY, 1997, 28 (10) :1189-1195
[34]   A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers [J].
Shiraishi, T ;
Watanabe, M ;
Muneyuki, T ;
Nakayama, T ;
Morita, J ;
Ito, H ;
Kotake, T ;
Yatani, R .
UROLOGIA INTERNATIONALIS, 1998, 61 (02) :90-94
[35]   p21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression [J].
Kouvidou, C ;
Stefanaki, K ;
Dai, Y ;
Tzardi, M ;
Koutsoubi, K ;
Darivianaki, K ;
Karidi, E ;
Rontogianni, D ;
Zois, E ;
Kakolyris, S ;
Georgoulias, V ;
Delides, G ;
Kanavaros, P .
ANTICANCER RESEARCH, 1997, 17 (4A) :2615-2619
[36]   S phase cell-cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway [J].
Wyllie, FS ;
Haughton, MF ;
Bond, JA ;
Rowson, JM ;
Jones, CJ ;
WynfordThomas, D .
ONCOGENE, 1996, 12 (05) :1077-1082
[37]   Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway [J].
Takagaki, N ;
Sowa, Y ;
Oki, T ;
Nakanishi, R ;
Yogosawa, S ;
Sakai, T .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (01) :185-189
[38]   WAF1 expression and p53 mutations in human colorectal cancers [J].
Wang, AJ ;
Yoshimi, N ;
Ino, N ;
Tanaka, T ;
Mori, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (02) :118-123
[39]   The prognostic significance of p53, p21(Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients [J].
Hirai, T ;
Kuwahara, M ;
Yoshida, K ;
Osaki, A ;
Toge, T .
ANTICANCER RESEARCH, 1999, 19 (5C) :4587-4591
[40]   Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma [J].
Gomyo, Y ;
Ikeda, M ;
Osaki, M ;
Tatebe, S ;
Tsujitani, S ;
Ikeguchi, M ;
Kaibara, N ;
Ito, H .
CANCER, 1997, 79 (11) :2067-2072